✦ LIBER ✦

A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults

✍ Scribed by Marshall, Helen S.; Richmond, Peter C.; Nissen, Michael D.; Wouters, Ann; Baber, James; Jiang, Qin; Anderson, Annaliesa S.; Jones, Thomas R.; Harris, Shannon L.; Jansen, Kathrin U.; Perez, John L.

Book ID: 123550406
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 633 KB
Volume: 31
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2013.01.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, phase 1/2 trial of the saf

A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants

✍ Martinon-Torres, Federico; Gimenez-Sanchez, Francisco; Bernaola-Iturbe, Enrique; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 651 KB

Safety, immunogenicity, and tolerability

Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial

✍ Richmond, Peter C; Marshall, Helen S; Nissen, Michael D; Jiang, Qin; Jansen, Kat 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 293 KB

Safety, immunogenicity, and antibody per

Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults

✍ Nilima Kshirsagar; Naidu Mur; Urmila Thatte; Nithya Gogtay; Simonetta Viviani; M 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 696 KB

Safety and immunogenicity of a quadrival

Safety and immunogenicity of a quadrivalent meningococcal conjugate vaccine (MenACYW-DT): Amulticenter, open-label, non-randomized, phase III clinical trial

✍ Yadav, Sangeeta; Manglani, M. V.; Ashwath Narayan, D. H.; Sharma, S.; Ravish, H. 📂 Article 📅 2014 🏛 Indian Academy of Pediatrics 🌐 English ⚖ 483 KB

A Novel Intramuscular Bivalent Norovirus

A Novel Intramuscular Bivalent Norovirus Virus-Like Particle Vaccine Candidate--Reactogenicity, Safety, and Immunogenicity in a Phase 1 Trial in Healthy Adults

✍ Treanor, J. J.; Atmar, R. L.; Frey, S. E.; Gormley, R.; Chen, W. H.; Ferreira, J 📂 Article 📅 2014 🏛 University of Chicago Press 🌐 English ⚖ 601 KB

Phase 1 first-in-human studies of the re

Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults

✍ Scott A. Halperin; Joanne M. Langley; Bruce Smith; Peter Wunderli; Lisa Kaufman; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 140 KB